US Stock MarketDetailed Quotes
MACK Merrimack Pharmaceuticals
- 15.130
- 0.0000.00%
Close May 17 16:00 ET
223.75MMarket Cap1.09P/E (TTM)
0.000High0.000Low0Volume0.000Open15.130Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)14.79MShares0.03152wk High1.01P/B146.21MFloat Cap0.02552wk Low--Dividend TTM9.66MShs Float0.130Historical High--Div YieldTTM0.00%Amplitude0.003Historical Low--Avg Price1Lot Size
Merrimack Pharmaceuticals Stock Forum
Sign in to post a comment
$Elevation Oncology (ELEV.US)$ $Merrimack Pharmaceuticals (MACK.US)$ Merrimack Gets $225 Million Milestone Payment, Schedules Meeting For Dissolution Plan
MT Newswires· 2 mins ago
Merrimack Pharmaceuticals (MACK) said late Wednesday it has received a $225 million milestone payment from Ipsen and called for a special stockholder meeting on May 10 to approve a plan of dissolution.
The milestone payment was due from Ipsen after the US Food and Drug Administration approved Onivyde as a first-line...
MT Newswires· 2 mins ago
Merrimack Pharmaceuticals (MACK) said late Wednesday it has received a $225 million milestone payment from Ipsen and called for a special stockholder meeting on May 10 to approve a plan of dissolution.
The milestone payment was due from Ipsen after the US Food and Drug Administration approved Onivyde as a first-line...
2
2
4 FDA approvals last week
1 PDUFA event left in Feb 2024
Last week’s PDUFAs:
$AstraZeneca (AZN.US)$ : Approved 2/16
⇒ Tagrisso (osimertinib) + chemotherapy
⇒ NSCLC
⇒ sNDA
⇒ PDUFA: Q1 2024
$Iovance Biotherapeutics (IOVA.US)$ : Approved 2/16
⇒ AMTAGVI™ (lifileucel)
⇒ Melanoma
⇒ BLA
⇒ PDUFA: 02/24/24
$ROCHE HOLDING AG (RHHBY.US)$ : Approved 2/16
⇒ Xolair® (omalizumab)
⇒ IgE-mediated food allergy
⇒ sBLA
⇒ PDUFA: Q1 2024
$IPSEY & $Merrimack Pharmaceuticals (MACK.US)$ : Approved 2/13
⇒ ...
1 PDUFA event left in Feb 2024
Last week’s PDUFAs:
$AstraZeneca (AZN.US)$ : Approved 2/16
⇒ Tagrisso (osimertinib) + chemotherapy
⇒ NSCLC
⇒ sNDA
⇒ PDUFA: Q1 2024
$Iovance Biotherapeutics (IOVA.US)$ : Approved 2/16
⇒ AMTAGVI™ (lifileucel)
⇒ Melanoma
⇒ BLA
⇒ PDUFA: 02/24/24
$ROCHE HOLDING AG (RHHBY.US)$ : Approved 2/16
⇒ Xolair® (omalizumab)
⇒ IgE-mediated food allergy
⇒ sBLA
⇒ PDUFA: Q1 2024
$IPSEY & $Merrimack Pharmaceuticals (MACK.US)$ : Approved 2/13
⇒ ...
8
1
📌Last week’s PDUFAs:
$Heron Therapeutics (HRTX.US)$ : Approved 1/23 🎉
⇒ ZYNRELEF
⇒ Postoperative pain
⇒ sNDA
⇒ PDUFA: 01/23/24
$Liquidia (LQDA.US)$ : NDA review ongoing 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA: 01/24/24
$Theratechnologies (THTX.US)$ : CRL 1/24 🙁
⇒ F8 Formulation of Tesamorelin
⇒ Excess abdominal fat in adults w/ HIV
⇒ sBLA
⇒ PDUFA: 01/22/24
$Sanofi (SNY.US)$ & $Regeneron Pharmaceuticals (REGN.US)$ : Approved 1/25 🎉
⇒ Dupixent
⇒ Eosinophilic esophagitis (pedia)
⇒ sB...
$Heron Therapeutics (HRTX.US)$ : Approved 1/23 🎉
⇒ ZYNRELEF
⇒ Postoperative pain
⇒ sNDA
⇒ PDUFA: 01/23/24
$Liquidia (LQDA.US)$ : NDA review ongoing 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA: 01/24/24
$Theratechnologies (THTX.US)$ : CRL 1/24 🙁
⇒ F8 Formulation of Tesamorelin
⇒ Excess abdominal fat in adults w/ HIV
⇒ sBLA
⇒ PDUFA: 01/22/24
$Sanofi (SNY.US)$ & $Regeneron Pharmaceuticals (REGN.US)$ : Approved 1/25 🎉
⇒ Dupixent
⇒ Eosinophilic esophagitis (pedia)
⇒ sB...
12
1
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Chairman Gary Crocker highlighted that interest income on cash and short term investments helped offset a significant portion of Q3 operating expenses. He also noted the company keeps observing developments in Ipsen's Onivyde(R) and Elevation's seribantumab programs.
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
Top Medical News of the Week
$Moderna (MRNA.US)$'s new Covid booster triggered a stronger immune response against omicron BA.5 and also appears to work against the emerging BQ.1.1 subvariant, according to the company.
The U.S. Covid public health emergency will remain in place past Jan. 11 after the federal government did no...
Top Medical News of the Week
$Moderna (MRNA.US)$'s new Covid booster triggered a stronger immune response against omicron BA.5 and also appears to work against the emerging BQ.1.1 subvariant, according to the company.
The U.S. Covid public health emergency will remain in place past Jan. 11 after the federal government did no...
8
2
Translated
1
$Merrimack Pharmaceuticals (MACK.US)$ $Apple (AAPL.US)$ $Tesla (TSLA.US)$ what you all doing move so little % @Alvinnnnnnn89did you buy at 6?
1
1
$Merrimack Pharmaceuticals (MACK.US)$ predictions?
1
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Jaguar8 : I love the milestone payment but dissolution weighed it down
Trytosaveabit OP Jaguar8 : Yup! I believe you’re correct